Related Experiment Video
Updated: Jun 27, 2025

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
Published on: January 23, 2019
Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside
Michele Correale1, Francesco Chirivì2, Ester Maria Lucia Bevere2
1Cardiothoracic Department, Policlinico Riuniti University Hospital, 71100 Foggia, Italy.
Pulmonary arterial hypertension involves complex molecular mechanisms, with endothelial dysfunction central to its progression. This review explores endothelial function in pulmonary arterial hypertension to aid future therapy development.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Endothelial Biology
Background:
- Pulmonary arterial hypertension (PAH) is a complex disease with unclear etiology.
- Endothelial dysfunction is a key factor in PAH pathogenesis.
- Genetic and environmental factors contribute to PAH onset.
Purpose of the Study:
- To provide a comprehensive review of endothelial function in pulmonary arterial hypertension.
- To elucidate the intricate relationship between endothelial health and pulmonary hypertension.
- To contribute to the development of novel therapeutic strategies for PAH.
Main Methods:
- Literature review of current research on endothelial function and pulmonary arterial hypertension.
- Synthesis of molecular mechanisms underlying endothelial dysfunction in PAH.
- Analysis of genetic and environmental influences on PAH development.
Main Results:
- Endothelial dysfunction significantly impacts pulmonary arterial hypertension progression.
- Multiple molecular pathways are implicated in the pathogenesis of PAH.
- Genetic predispositions and environmental exposures play a role in PAH etiology.
Conclusions:
- Understanding endothelial dysfunction is crucial for PAH management.
- Further research into endothelial pathways may reveal new therapeutic targets.
- A comprehensive approach is needed to address the complexities of pulmonary arterial hypertension.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

